Low pre-operative vitamin D associated with lower baseline PROMs but greater improvement following total joint arthroplasty
Article History
-
Received: ,
Accepted: ,
Abstract
Abstract
This study investigated whether low pre-operative 25-OH-vitamin-D (25(OH)D) is associated with worse patient-reported outcome measures (PROMs) and higher odds of post-operative complications following TJA in a diverse population.
This was a retrospective study of patients undergoing total hip (THA) or knee arthroplasty (TKA) at an urban tertiary care center between 2020 and 2023. A total of 488 patients were included, representing 538 surgeries. Patients identified as 25(OH)D deficient (<12 nmol/L) or insufficient (12–30 nmol/L) were prescribed supplementation before or at the time of surgery per institution protocol. We analyzed the relationship between 25(OH)D level and Hip dysfunction and Osteoarthritis Outcome Score for Joint Replacement (HOOS, JR) or Knee injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS, JR) pre-operatively, at 6 weeks, and at 90-days post-surgery, as well as 90-day complications.
Low pre-operative 25(OH)D was observed in 46.5% of surgeries and was associated with lower pre-operative HOOS, JR score (P = 0.002). Improvement in HOOS, JR score at 90-days post-operatively was significantly greater in the 25(OH)D deficient group (P = 0.043). No statistical difference was found among KOOS, JR scores. Low pre-operative 25(OH)D did not increase odds of re-operation (P = 0.484), readmission (P = 0.385), wound complications (P = 0.595), or overall complications (P = 0.656).
Our results suggest that low 25(OH)D is associated with lower pre-operative HOOS, JR score and greater improvement in HOOS, JR score following THA; similar trends were appreciated in TKA but were not significant. TJA coupled with 25(OH)D supplementation in patients who have low 25(OH)D may result in similar post-operative outcomes as those with normal pre-operative 25(OH)D.
Keywords
This article was originally published by Reed Elsevier India Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
1 Introduction
25-OH-vitamin-D (25(OH)D) plays a key role in maintaining appropriate calcium and phosphate levels in the body, and it is thought to be an essential component of overall musculoskeletal health.1 Unfortunately, 25(OH)D deficiency is becoming increasingly prevalent, and it has been implicated in the development of important orthopaedic conditions, such as arthritis.2 Low 25(OH)D levels have been correlated with reduced bone quality and impaired muscle function, as well as poorer balance, greater pain, and difficulty with ambulation.3–5 Studies have also suggested that patients who have low 25(OH)D levels and ultimately undergo total hip arthroplasty (THA) or total knee arthroplasty (TKA) tend to have lower pre-operative function and poorer outcomes following surgery.6,7 Additionally, there is concern that low 25(OH)D levels, indicating poor bone quality, may compromise the success of press-fit implants utilized in total joint arthroplasty (TJA).8,9 As one element of pre-operative optimization, some institutions have developed 25(OH)D supplementation protocols, which have demonstrated success in improvement of joint pain and reduction in symptoms following TJA.10–13 In fact, prior literature has posited that post-operative 25(OH)D supplementation may have additive effects in increasing patient quality of life and satisfaction.12–14
While previous investigations have shown impressive rates of 25(OH)D deficiency among patients undergoing TJA, the prevalence likely varies significantly among different patient populations. Studies conducted in Europe and the United States have found varying rates of 25(OH)D deficiency among patients undergoing TJA or those who have osteoarthritis, ranging from as low as 15% to as high as 86%.7,15–17 However, most of these studies investigated majority-White populations; current literature suggests that Black individuals may experience up to 15–20 times higher rates of deficiency than their White counterparts, resulting in significant morbidity.4,5 Furthermore, the definition of 25(OH)D deficiency among these studies is inconsistent.7,15–18 Current guidelines have subsequently defined 25(OH)D deficiency as <12 nmol/L and insufficiency as 12–30 nmol/L.19–21 This study aimed to investigate if low pre-operative 25(OH)D is associated with inferior patient-reported outcome measures (PROMs) and higher odds of 90-day post-operative complications following TJA in a diverse population with high prevalence of low 25(OH)D.
2 Methods
2.1 Study design
This was a retrospective comparative cohort study of patients who underwent TJA at a tertiary care center. Approval from the Institutional review board was received with waivers of both written consent and HIPAA authorization. Chart review was conducted to collect pre-operative, day-of-surgery, 6-week post-operative, 90-day post-operative outcomes, and 25(OH)D treatment data.
2.2 Setting
We performed this investigation at a single, urban, tertiary care center from July 2021 to August 2023.
2.3 Participants
English-speaking patients 18 years of age or older who underwent elective primary or revision THA or TKA between 2020 and 2023 were eligible for study inclusion with the aim of recruiting 500 patients. Non-English-speaking patients, patients who underwent treatment for acute infection (only second stage revisions free from infection were included), and patients who underwent TJA for fracture were excluded from the study. Patients were seen pre-operatively, at 6 weeks post-operatively, and at 90 days post-operatively.
2.4 Variables
Pre-operative data collected consisted of the subject's medical record number, age, body mass index, race, sex, smoking history, diagnosis, KOOS, JR/HOOS, JR score, 25(OH)D level, and comorbidities. Day-of-surgery data collected consisted of surgical date, surgery performed, length of stay, length of surgery, tourniquet time (knee surgery only), intra-operative blood transfusion, and estimated blood loss. 6-week post-operative data included KOOS, JR/HOOS, JR score. 90-day post-operative data included KOOS, JR/HOOS, JR score, readmissions, and complications. Complications data was grouped as follows: return to OR, wound complications (cellulitis, surgical site infections, dehiscence, delayed wound healing, hematoma, seroma, excessive edema/swelling, allergic reaction), prosthetic joint infection, and overall complications (including medical complications).
All patients undergoing TJA completed pre-operative 25(OH)D testing and were prescribed supplementation per institutional protocol if 25(OH)D deficient (<12 nmol/L) or insufficient (12–30 nmol/L); deficient patients were prescribed 50,000 units ergocalciferol once weekly for six weeks, and insufficient patients were prescribed 800 units cholecalciferol daily for six weeks. Supplementation typically began within 2 weeks of the surgical date.
2.5 Data sources/management
Data were collected from electronic medical records at our institution. KOOS, JR. and HOOS, JR. scores (1–100), as well as 25(OH)D levels (ng/mL), are numeric and may be compared between patients. There were three groups of 25(OH)D levels (ng/mL): <12, 12–30, and >30. Post-operative complications were dichotomous variables (“Yes” or “No”).
2.6 Statistical method
The relationship between categorical pre-operative variables and 25(OH)D status was assessed utilizing Chi-square and Fisher Exact tests. The Kruskal-Wallis equality-of-populations rank test was utilized to analyze non-normal continuous pre-operative variables, as determined by the Shapiro-Wilk test. The associations between 25(OH)D level and re-operation, readmission, and wound complications were analyzed utilizing mixed effects logistic regression. The association of 25(OH)D level with likelihood of experiencing any complication was investigated using Chi-square and Fisher's exact tests. The relationships among 25(OH)D level and improvement in KOOS, JR and HOOS, JR scores at 6 weeks and 90 days post-operatively were determined utilizing the Kruskal-Wallis equality-of-populations rank test. Mixed-effects regression and multivariate linear mixed models were utilized to analyze the overall relationship of KOOS, JR and HOOS, JR scores with 25(OH)D levels over time while controlling for all independent variables significantly associated with each outcome measure.
3 Results
3.1 Participants
There were 488 patients who ultimately met the inclusion criteria, representing 538 TJA surgeries; 22 surgeries without pre-operative 25(OH)D data were excluded from 25(OH)D analyses.
3.2 Descriptive data
The median pre-operative 25(OH)D level was 32 nmol/L (IQR (interquartile range): 23–44 nmol/L), with a range of values spanning the continuum of reportable levels (<7 nmol/L to >100 nmol/L). Of 516 total TJA surgeries, 46.5% (240) had low preoperative 25(OH)D. Of the 240 surgeries with pre-operative 25(OH)D insufficiency or deficiency, 164 (71.3%) were prescribed 25(OH)D pre-operatively or at the time of surgery.
At baseline, patients with low 25(OH)D were significantly likelier to be younger, obese, and Black. Obese individuals had approximately 1.68 times greater odds of having low 25(OH)D relative to non-obese individuals, and Black individuals had approximately 2.92 times increased odds of having low 25(OH)D relative to White individuals.
3.3 Main results
Patients with low 25(OH)D also had significantly lower median pre-operative HOOS, JR scores, representing more severe patient-reported hip disability (Table A.1).Improvement in HOOS, JR score at 90 days post-operatively was found to be significantly different among the 25(OH)D groups, with the greatest improvement observed in those with 25(OH)D deficiency (P = 0.043) (Figures A.1 & A.2). Lower pre-operative KOOS, JR score and greater improvement in KOOS, JR score by 90 days post-operatively were similarly observed among patients who had 25(OH)D deficiency; however, these observations did not achieve significance. Furthermore, analysis of linear mixed models found HOOS, JR scores to be significantly higher overall in patients who have pre-operative 25(OH)D >30 nmol/L relative to patients with 25(OH)D deficiency when controlling for time measured (P = 0.023); no significant association was found between overall KOOS, JR scores and 25(OH)D status.
Overall, complications occurred following 75 (13.94%) surgeries (Figure A.3). Mixed-effects logistic regression analysis revealed those with low 25(OH)D did not have higher odds of re-operation (P = 0.484), readmission (P = 0.385), wound complications (P = 0.595), and overall complications (P = 0.656) relative to those with higher 25(OH)D levels.
4 Discussion
4.1 Key results
This is one of the largest studies investigating the effect of 25(OH)D levels on TJA outcomes. We found that despite lower pre-operative HOOS, JR scores, patients with low 25(OH)D showed greater patient-reported improvements by 90 days post-operatively. Our results suggest that THA in patients with low 25(OH)D may result in similar patient-reported outcomes relative to those with normal pre-operative 25(OH)D despite lower baseline scores. Similar trends were also seen in KOOS, JR scores among those who had 25(OH)D deficiency, and although these trends were not significant, they may reflect an overarching pattern.
Additionally, while there was a trend toward higher odds of readmission and overall post-operative complications with lower pre-operative 25(OH)D, these differences in odds were not statistically significant. The comparable odds across all complication groupings among the 25(OH)D groups parallel the post-operative findings observed in PROMs; these results further support the premise that individuals who have low 25(OH)D may experience similar outcomes following TJA relative to patients with normal pre-operative 25(OH)D levels.
Given that the majority of 25(OH)D deficient/insufficient patients appropriately received supplementation, it is conceivable that this 25(OH)D supplementation may have contributed to the 90-day findings we observed, including similar PROMs and odds of complications. However, lack of laboratory follow-up within this study restricted our capacity to track improvement in 25(OH)D level and definitively draw this conclusion. While previous studies have reported early success with 25(OH)D supplementation pre-operatively by a similar protocol,22 future studies should aim to include longer-term records of 25(OH)D concentrations and outcomes post-supplementation.
Bone quality is an important consideration in orthopaedic care and has become increasingly relevant to TJA as the utilization of cementless implants rises in popularity.23,24 Prior studies have suggested that patients who have low 25(OH)D levels demonstrate inferior outcomes following TJA, such as persistent pain after TKA, higher post-operative pain scores overall,25 lower likelihood of reporting excellent PROMs following THA,16 and poorer functional scores post-operatively.26 Perhaps relatedly, low 25(OH)D has also been associated with lengthier hospital stays after elective TJA and has even been posited to result in higher rates of prosthetic joint infections.15,17,27 Our results did not demonstrate a difference in odds of complication by 25(OH)D level, perhaps in part due to concomitant, aggressive 25(OH)D supplementation throughout the perioperative period. Further research on the effects of 25(OH)D supplementation on outcomes after TJA is warranted, particularly in light of the current trend toward cementless fixation.
Unlike prior investigations, our study examined a predominantly Black population. As anticipated, nearly half (46.5%) of all patients had low pre-operative 25(OH)D, and Black patients were disproportionately impacted. High body mass index was also found to be a significant risk factor, aligning with current literature,28–30 as was younger age, despite advanced age generally being considered an independent risk factor for low 25(OH)D.31,32 Notably, smoking history was not significantly related with 25(OH)D status in our study.33,34
While universal screening to identify low 25(OH)D may not be practical or cost-effective for all surgeons, selective screening may improve outcomes. Our results suggest that obesity, age, and race may be effective indicators of high risk patients, and the use of risk factors to inform selective screening has been supported in past literature.25,26,35–38 Given that Black patients were found to have almost three times greater odds of experiencing 25(OH)D deficiency/insufficiency compared to White patients, they are particularly vulnerable to the associated complications—thus, 25(OH)D supplementation may be especially important in this population. This study highlights the opportunity for orthopaedic surgeons to take ownership over bone health with comprehensive optimization protocols that identify and treat 25(OH)D deficiency.
This study's strengths include its large population size and unique patient demographics. However, the investigation does have limitations, such as those characteristic of a retrospective design. Furthermore, the study may be underpowered to identify significant differences among relatively low complication rates. Additionally, the inclusion of revision surgeries in the study cohort added heterogeneity to the data, though revisions constituted only a small portion of overall surgeries (roughly 5%) and did not include cases resulting from infection or fracture. Furthermore, adherence to supplementation and day-of-surgery vitamin D levels were unable to be evaluated, and supplementation may have been underreported due to wide availability of over-the-counter 25(OH)D. In addition, some investigations have posited that socioeconomic status (SES) may be associated with PROMs, but we did not have SES data available for analysis, which may represent a possible confounder.39,40 Incomplete data on PROMs remains a general limitation, though there is hope that this will be surmountable in future studies given recent changes to national reporting requirements for PROMs.
5 Conclusion
Our findings demonstrate that low 25(OH)D is linked to lower pre-operative HOOS, JR score and greater improvement in HOOS, JR score following THA; similar trends were appreciated in TKA but were not statistically significant. Overall, low 25(OH)D levels are related to lower HOOS, JR and KOOS, JR scores before TJA, and nearly half of our diverse study population demonstrated low 25(OH)D levels pre-operatively. Surgeons performing TJA in diverse populations should be aware of high rates of 25(OH)D deficiency and its association with PROMs, and they should test and treat 25(OH)D deficiency accordingly as part of comprehensive pre-operative patient optimization. Future investigations should continue to study the effects of 25(OH)D on surgical outcomes in large and diverse patient populations, as well as explore its role in arthritis and overall musculoskeletal health.
Patient consent statement
Informed, written patient consent was appropriately obtained for this case report.
Ethical approval and patient consent
This study was approved by the authors’ institutional Institutional Review Board (IRB) and was IRB20-0278. This study has been conducted in accordance with the ethical principles mentioned in the Declaration of Helsinski and all patients consented to participation in the study
Financial support and sponsorship
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Data statement
Data available upon request to corresponding author.
CRediT authorship contribution statement
Sarthak Aggarwal: Conceptualization, Methodology, Investigation, Writing – original draft, Writing – review & editing, Visualization, Project administration. Malik Scott: Methodology, Investigation, Writing – original draft. Michael Koch: Methodology, Investigation, Resources, Data curation, Writing – review & editing. Chuanhong Liao: Methodology, Formal analysis, Data curation, Writing – review & editing. Sara J.S. Wallace: Conceptualization, Methodology, Investigation, Writing – review & editing, Visualization, Supervision, Project administration, Funding acquisition.
References
- From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health1. Am J Clin Nutr. 2008;88:491S-499S.
- [Google Scholar]
- The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. 2017;18:153-165.
- [Google Scholar]
- 25-Hydroxyvitamin D and osteoarthritis: a meta-analysis including new data. Semin Arthritis Rheum. 2016;45:539-546.
- [Google Scholar]
- Obesity and efficacy of vitamin D3 supplementation in healthy black adults. Cancer Causes Control. 2020;31:303-307.
- [Google Scholar]
- Combined associations of 25-hydroxivitamin D and parathyroid hormone with diabetes risk and associated comorbidities among U.S. white and black women. Nutr Diabetes. 2021;11:29.
- [Google Scholar]
- Effect of preoperative vitamin D levels on functional performance after total knee arthroplasty. Clin Orthop Surg. 2016;8:153-156.
- [Google Scholar]
- High prevalence of vitamin D deficiency in elderly patients with advanced osteoarthritis scheduled for total knee replacement associated with poorer preoperative functional state. Ann R Coll Surg Engl. 2013;95:569-572.
- [Google Scholar]
- A comparison of risks and benefits regarding hip arthroplasty fixation. J Am Acad Orthop Surg Glob Res Rev. 2021;5:e21.
- [Google Scholar]
- Bone defects in revision total knee arthroplasty and management. Orthop Surg. 2019;11:15-24.
- [Google Scholar]
- Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European society of clinical and economical aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO) working group. Aging Clin Exp Res. 2022;34:2603-2623.
- [Google Scholar]
- Melanin has a small inhibitory effect on cutaneous vitamin D synthesis: a comparison of extreme phenotypes. J Invest Dermatol. 2020;140:1418-1426.e1.
- [Google Scholar]
- High-dose vitamin D supplementation can correct hypovitaminosis D prior to total knee arthroplasty. J Arthroplasty. 2022;37:274-278.
- [Google Scholar]
- Vitamin D3 supplementation prior to total knee arthroplasty: a randomized controlled trial. J Arthroplasty. 2023;38:S114-S119.
- [Google Scholar]
- The effect of vitamin D supplementation on outcomes following total hip or knee arthroplasty surgery: a rapid systematic review of current evidence. EFORT Open Rev. 2022;7:305-311.
- [Google Scholar]
- Is there an association between periprosthetic joint infection and low vitamin D levels? Int Orthop. 2014;38:1499-1504.
- [Google Scholar]
- Vitamin D deficiency in patients with osteoarthritis undergoing total hip replacement: a cause for concern? The Journal of Bone & Joint Surgery British. 2010;92-B:496-499.
- [Google Scholar]
- Is there an association between low serum 25-OH-D levels and the length of hospital stay in orthopaedic patients after arthroplasty? J Orthop Traumatol. 2016;17:297-302.
- [Google Scholar]
- Positive association between serum 25‐hydroxyvitamin D level and bone density in osteoarthritis - bischoff‐Ferrari. 2005
- [Google Scholar]
- Global consensus recommendations on prevention and management of nutritional rickets. J Clin Endocrinol Metabol. 2016;101:394-415.
- [Google Scholar]
- Vitamin D insufficiency: definition, diagnosis and management. Best Pract Res Clin Endocrinol Metabol. 2018;32:669-684.
- [Google Scholar]
- Controversies in vitamin D: summary statement from an international conference. J Clin Endocrinol Metabol. 2019;104:234-240.
- [Google Scholar]
- Effect of vitamin D3 and omega-3 fatty acid supplementation on risk of frailty: an ancillary study of a randomized clinical trial. JAMA Netw Open. 2022;5
- [Google Scholar]
- Effect of hypovitaminosis D on postoperative pain outcomes and short-term health-related quality of life after knee arthroplasty. Medicine (Baltim). 2015;94
- [Google Scholar]
- Vitamin D deficiency adversely affects early post-operative functional outcomes after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2017;25:3424-3430.
- [Google Scholar]
- Fewer complications following revision hip and knee arthroplasty in patients with normal vitamin D levels. J Arthroplasty. 2017;32:S193-S196.
- [Google Scholar]
- Serum 25-hydroxyvitamin D levels and metabolic health status in extremely obese individuals. Obesity. 2014;22:2539-2543.
- [Google Scholar]
- Decreased bioavailability of vitamin D in obesity123. Am J Clin Nutr. 2000;72:690-693.
- [Google Scholar]
- The association of serum vitamin D with incident diabetes in an African American population. Nutr Diabetes. 2022;12:43.
- [Google Scholar]
- Vitamin D deficiency, smoking, and lung function in the normative aging study. Am J Respir Crit Care Med. 2012;186:616-621.
- [Google Scholar]
- Smoking behavior and circulating vitamin D levels in adults: a meta‐analysis. Food Sci Nutr. 2021;9:5820-5832.
- [Google Scholar]
- Vitamin D and Childhood Asthma - causation and contribution to disease activity. Curr Opin Allergy Clin Immunol. 2019;19:126-131.
- [Google Scholar]
- Vitamin D supplementation for the prevention of depression and poor physical function in older persons: the D-Vitaal study, a randomized clinical trial. Am J Clin Nutr. 2019;110:1119-1130.
- [Google Scholar]
- Serum vitamin d inversely correlates with depression scores in people with multiple sclerosis. Multip Sclero Relat Disorder. 2021;48
- [Google Scholar]
- Vitamin D status was not associated with anxiety, depression, or health-related quality of life in Middle Eastern and African-born immigrants in Sweden. Nutr Res. 2020;75:109-118.
- [Google Scholar]
- Effects of socioeconomic status on patient-reported outcome after surgically treated trigger finger: a retrospective national registry-based study. BMJ Open. 2023;13
- [Google Scholar]
- Socioeconomic status affects patient-reported outcome measures in total hip and knee arthroplasty: a retrospective Dutch registry study. J Arthroplasty 2024
- [Google Scholar]

